Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial
CONCLUSION: Early combination triple therapy showed better efficacy and durability than the single add-on (dual) therapy. Therefore, combination therapy with metformin, alogliptin, and pioglitazone is a valuable early treatment option for T2DM poorly controlled with metformin monotherapy.PMID:38650099 | DOI:10.4093/dmj.2023.0259 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 23, 2024 Category: Endocrinology Authors: Ji-Yeon Park Joonyub Lee Yoon-Hee Choi Kyung Wan Min Kyung Ah Han Kyu Jeung Ahn Soo Lim Young-Hyun Kim Chul Woo Ahn Kyung Mook Choi Kun-Ho Yoon Practical Evidence of Antidiabetic Combination Therapy in Korea (PEAK) study investigators Source Type: research
Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
This article reviews the recent research progress of GLP-1 in lipid metabolism.PMID:38650100 | DOI:10.4093/dmj.2023.0277 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 23, 2024 Category: Endocrinology Authors: Tong Bu Ziyan Sun Yi Pan Xia Deng Guoyue Yuan Source Type: research
DGAT2 Plays a Crucial Role to Control ESRRAPROX1 Transcriptional Network to Maintain Hepatic Mitochondrial Sustainability
CONCLUSION: DGAT2 sustains the stability of mitochondria in hepatoma via suppressing ESRRA-PROX1 transcriptional network and hinders HCC from shifting towards glycolytic metabolism, which lowers cell proliferation.PMID:38644620 | DOI:10.4093/dmj.2023.0368 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 22, 2024 Category: Endocrinology Authors: Yoseob Lee Yeseong Hwang Minki Kim Hyeonuk Jeon Seyeon Joo Sungsoon Fang Jae-Woo Kim Source Type: research
Enhancing Patient Outcomes: Prioritizing SGLT2is and GLP-1RAs in Diabetes with CVD
Diabetes Metab J. 2024 Mar;48(2):208-212. doi: 10.4093/dmj.2024.0096. Epub 2024 Mar 22.NO ABSTRACTPMID:38556703 | PMC:PMC10995481 | DOI:10.4093/dmj.2024.0096 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Gwanpyo Koh Source Type: research
SGLT2 Inhibitors and GLP-1 Agonists: A Beacon of Hope for Stroke Prevention in Diabetes
Diabetes Metab J. 2024 Mar;48(2):213-214. doi: 10.4093/dmj.2024.0079. Epub 2024 Mar 22.NO ABSTRACTPMID:38556704 | PMC:PMC10995490 | DOI:10.4093/dmj.2024.0079 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Jae-Han Jeon Source Type: research
Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis (Diabetes Metab J 2024;48:134-45)
Diabetes Metab J. 2024 Mar;48(2):321-322. doi: 10.4093/dmj.2024.0070. Epub 2024 Mar 22.NO ABSTRACTPMID:38556705 | PMC:PMC10995497 | DOI:10.4093/dmj.2024.0070 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Jin Hwa Kim Source Type: research
Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis (Diabetes Metab J 2024;48:134-45)
Diabetes Metab J. 2024 Mar;48(2):323-324. doi: 10.4093/dmj.2024.0085. Epub 2024 Mar 22.NO ABSTRACTPMID:38556706 | PMC:PMC10995488 | DOI:10.4093/dmj.2024.0085 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Shu Yi Wang Lin Xu Source Type: research
Enhancing Patient Outcomes: Prioritizing SGLT2is and GLP-1RAs in Diabetes with CVD
Diabetes Metab J. 2024 Mar;48(2):208-212. doi: 10.4093/dmj.2024.0096. Epub 2024 Mar 22.NO ABSTRACTPMID:38556703 | PMC:PMC10995481 | DOI:10.4093/dmj.2024.0096 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Gwanpyo Koh Source Type: research
SGLT2 Inhibitors and GLP-1 Agonists: A Beacon of Hope for Stroke Prevention in Diabetes
Diabetes Metab J. 2024 Mar;48(2):213-214. doi: 10.4093/dmj.2024.0079. Epub 2024 Mar 22.NO ABSTRACTPMID:38556704 | PMC:PMC10995490 | DOI:10.4093/dmj.2024.0079 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Jae-Han Jeon Source Type: research
Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis (Diabetes Metab J 2024;48:134-45)
Diabetes Metab J. 2024 Mar;48(2):321-322. doi: 10.4093/dmj.2024.0070. Epub 2024 Mar 22.NO ABSTRACTPMID:38556705 | PMC:PMC10995497 | DOI:10.4093/dmj.2024.0070 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Jin Hwa Kim Source Type: research
Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis (Diabetes Metab J 2024;48:134-45)
Diabetes Metab J. 2024 Mar;48(2):323-324. doi: 10.4093/dmj.2024.0085. Epub 2024 Mar 22.NO ABSTRACTPMID:38556706 | PMC:PMC10995488 | DOI:10.4093/dmj.2024.0085 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Shu Yi Wang Lin Xu Source Type: research
Enhancing Patient Outcomes: Prioritizing SGLT2is and GLP-1RAs in Diabetes with CVD
Diabetes Metab J. 2024 Mar;48(2):208-212. doi: 10.4093/dmj.2024.0096. Epub 2024 Mar 22.NO ABSTRACTPMID:38556703 | PMC:PMC10995481 | DOI:10.4093/dmj.2024.0096 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Gwanpyo Koh Source Type: research
SGLT2 Inhibitors and GLP-1 Agonists: A Beacon of Hope for Stroke Prevention in Diabetes
Diabetes Metab J. 2024 Mar;48(2):213-214. doi: 10.4093/dmj.2024.0079. Epub 2024 Mar 22.NO ABSTRACTPMID:38556704 | PMC:PMC10995490 | DOI:10.4093/dmj.2024.0079 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Jae-Han Jeon Source Type: research
Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis (Diabetes Metab J 2024;48:134-45)
Diabetes Metab J. 2024 Mar;48(2):321-322. doi: 10.4093/dmj.2024.0070. Epub 2024 Mar 22.NO ABSTRACTPMID:38556705 | PMC:PMC10995497 | DOI:10.4093/dmj.2024.0070 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Jin Hwa Kim Source Type: research
Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis (Diabetes Metab J 2024;48:134-45)
Diabetes Metab J. 2024 Mar;48(2):323-324. doi: 10.4093/dmj.2024.0085. Epub 2024 Mar 22.NO ABSTRACTPMID:38556706 | PMC:PMC10995488 | DOI:10.4093/dmj.2024.0085 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Shu Yi Wang Lin Xu Source Type: research
